Economic research on Alzheimer disease: A review of the literature

Alzheimer Disease and Associated Disorders

Volumn 11, Issue SUPPL. 6, 1997, Pages 135-145

  Ernst, Richard L ^a   Hay, Joel W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Cost; Cost effectiveness; Economics

Indexed keywords

ALZHEIMER DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; METHODOLOGY; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; CAREGIVERS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH SERVICES RESEARCH; HUMANS;

EID: 0031473556     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Alchian A. Cost. In: Sills DL, ed. International encyclopedia of the social sciences. New York: Macmillan, 1968:404-15.
2. Bachman DL, Wolf PA, Linn R, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-9.
3. Beard CM, Kokmen E, Offord K, et al. Is the prevalence of dementia changing? Neurology 1991;41:1911-4.
4. Bloom BS, Hillman AL, Fendrick AM, et al. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Int Med 1993;118:298-306.
5. Collins CE, Given BA, Given CW. Interventions with family caregivers of persons with Alzheimer's disease. Nursing Clin North Am 1994; 29:195-207.
6. Corrada M, Brockmeyer R, Kawas C. Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol 1995; 24:1000-5.
7. Coughlin TA, Liu K. Health care costs of older persons with cognitive impairments. Gerontologist 1989;29:173-82.
8. Davis KL, Thal LJ, Gamzu ER, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253-9.
9. Detsky AS, Naglie, IG. A clinician's guide to cost-effectiveness analysis. Ann Int Med 1990;113:147-54.
10. Edwards CM, Mackintosh DR, Clair D. Patient cost and economic burden due to accidental injuries. Washington, D.C.: National Institute for Advanced Studies, 1981.
11. Elam JT, Graney MJ, Beaver T, et al. Comparison of subjective ratings of function with observed functional ability of frail older persons. Am J Public Health 1991;81:1127-30.
12. Epstein AM, Hall JA, Tognetti J, et al. Using proxies to evaluate quality of life: can they provide valid information about patients' health status and satisfaction with medical care? Med Care 1989;27:S91-8.
13. Ernst R, Hay J. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;8:1261-3.
14. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551-6.
15. Farlow M, Gracon SI, Hershey LA, et al. A controlled trial of tacrine in Alzheimer's disease. JAMA 1992;268:2523-9.
16. Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. Pharmacoeconomics 1992;1:20-32.
17. Gallagher TJ, Wagenfeld MO, Baro F, et al. Sense of coherence, coping and caregiver role overload. Soc Sci Med 1994;39:1615-22.
18. George LK, Gwyther LP. Caregiver well-being: a multidimensional examination of family caregivers of demented adults. Gerontologist 1986;26:253-9.
19. Goddeeris JH. Theoretical considerations on the cost of illness. J Health Econ 1983;2:149-9.
20. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-18.
21. Haley WE. Levine EG, Brown SL, et al. Psychological, social, and health consequences of caring for a relative with senile dementia. J Am Geriatr Soc 1987;35:405-11.
22. Hay JW, Ernst RL. The economic costs of Alzheimer's disease. Am J Public Health 1987:77:1169-75.
23. Hooker K, Monahan D, Shifren D, et al. Mental and physical health of spouse caregivers: the role of personality. Psychol Aging 1992;7: 367-75.
24. Hu T, Huang L, Cartwright WS. Evaluation of the costs of caring for the senile demented elderly: a pilot study. Gerontologist 1986;26:158-63.
25. Huang L, Cartwright WS, Hu T. The economic cost of senile dementia in the United States, 1985. Pub Health Rep 1988;103:3-7.
26. Hunink GM, Wong JB, Donaldson MC, et al. Revascularization for femopopliteal disease. JAMA 1995;274:165-71.
27. Johannesson M, Johansson P-O, Kriström B, Borgquist L, Jonssön B. Willingness to pay for lipid lowering: a health production function approach. Applied Econ 1993;25:1023-31.
28. Johannesson M, Jönsson B. Willingness to pay for antihypertensive therapy - results of a Swedish pilot study. J Health Econ 1991;10:461-74.
29. Johansson P-O. Evaluating health risks: an economic approach. Cambridge: Cambridge University Press, 1995.
30. Kiyak HA, Teri L, Borson S. Physical and functional health assessment in normal aging and in Alzheimer's disease: self-reports vs. family reports. Gerontologist 1994;34:324-30.
31. Knapp MJ, Gracon SI, Davis CS, Solomon PR. Efficacy and safety of high-dose tacrine - a 30-week evaluation. Alzheimer Dis Assoc Disord 1994a;8(Suppl 2):S22-S31.
32. Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994b;271:985-91.
33. Knopman D. Tacrine for Alzheimer's disease. Pharmacoeconomics 1995;7:275-9.
34. Knopman D, Schneider L, Davis K, et al. Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Neurology 1996;47:166-77.
35. Kokmen E, Beard CM, O'Brien PC, et al. Epidemiology of dementia in Rochester, Minnesota. Mayo Clin Proc 1996;71:275-82.
36. Landefeld JS, Seskin EP. The economic value of life: linking theory to practice. Am J Public Health 1982;72:555-66.
37. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-81.
38. Lawton MP. Quality of live in Alzheimer disease. Alzheimer Dis Assoc Disord 1994;8(Suppl 3):138-50.
39. Levit KR, Lazenby HC, Sivarajan L, et al. Dataview: national health expenditures, 1994. Health Care Finan Rev 1996; 17:205-42.
40. Logsdon RG, Teri L. Depression in Alzheimer's disease patients: caregivers as surrogate reporters. J Am Geriatr Soc 1995;43:150-5.
41. Maltby N, Broe GA, Creasey H, et al. Efficacy of tacrine and lecithin in mild-to-moderate Alzheimers disease - double-blind trial. BMJ 1994;308:879-83.
42. Manton KG, Vertrees JC, Woodbury MA. Functionally and medically defined subgroups of nursing home populations. Health Care Finan Rev 1990;12:47-62.
43. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995; 332:1418-24.
44. Max W, Webber P, Fox P. Alzheimer's disease: the unpaid burden of caring. J Aging Health 1995;7:179-99.
45. Mishan, E.J. Cost-benefit analysis, 4th ed. London: Unwin Hyman, 1988.
46. Mittelman M, Ferris S, Shulman E, et al. Efficacy of multicomponent individualized treatment to improve the well-being of Alzheimer's caregivers. In: Light E, Niederehe G, Lebowitz BD, eds. Stress effects on family caregivers of Alzheimer's patients: research and interventions. New York: Springer Publishing, 1994:156-84.
47. Mittelman MS, Ferris SH, Shulman E, et al. A comprehensive support program: effect on depression in spouse-caregivers of AD patients. Gerontologist 1995;35:792-802.
48. Mittelman MS, Ferris SH, Shulman E, et al. The effects of a multicomponent support program on spouse-caregivers of Alzheimer's disease patients: results of a treatment/control study. In: Heston LL, ed. Progress in Alzheimer s disease and similar conditions. Washington, D.C.: American Psychiatric Press, 1997:259-75.
49. Mittelman M, Ferris S, Steinberg G, et al. An intervention that delays institutionalization of Alzheimer's disease patients: treatment of spouse-caregivers. Gerontologist 1993;33:730-40.
50. Moye J, Robiner WN, Mackenzie TB. Depression in Alzheimer patients: discrepancies between patient and caregiver reports. Alzheimer Dis Assoc Disord 1993;7:187-201.
51. Østbye T, Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J 1994;151:1457-64.
52. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer's disease in a retirement community. Am J Epidemiol 1987;125:420-36.
53. Reis, MF, Andres D, Gold DP, et al. Personality traits as determinants of burden and health complaints in caregiving. Int J Aging Hum Dev 1994;39:257-71.
54. Rice DP, Fox PJ, Max W, et al. The burden of caring for Alzheimer's disease patients. In: Proceedings of the 1991 Public Health Conference on Records and Statistics. Washington, D.C.: US DHHS, 1992.
55. Rice DP, Hodgson TA. The value of human life revisited. Am J Public Health 1982;72:536-8.
56. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Finan Rev 1985;7:61-80.
57. Russell LB. Is prevention better than cure? Washington, D.C.: Brookings Institution, 1986.
58. Shepard DS, Thompson MS. First principles of cost-effectiveness analysis in health. Pub Health Rep 1979;94:535-43.
59. Stommel M, Collins CE, Given BA. The costs of family contributions to the care of persons with dementia. Gerontologist 1994;34:199-205.
60. Strauss ME, Pasupathi M, Chatterjee A. Concordance between observers in descriptions of personality change in Alzheimer's disease. Psychol Aging 1993;8:475-80.
61. Thompson MS, Read JL, Liang M. Feasibility of willingness to pay measurement in chronic arthritis. Med Dec Making 1984;4:195-215.
62. Toseland RW, Rossiter CM. Group interventions to support family caregivers: a review and analysis. Gerontologist 1989;29:438-48.
63. Weiler PG, Lubben JE, Chi I. Cognitive impairment and hospital use. Am J Public Health 1991;81:1153-7.
64. Weinberger M, Gold T, Divine GW, et al. Expenditures in caring for patients with dementia who live at home. Am J Public Health 1993;83:338-41.
65. Weinberger M, Gold DT, Divine GW, et al. Social service interventions for caregivers of patients with dementia; impact on health care utilization and expenditures. J Am Geriatr Soc 1994;41:153-6.
66. Weinstein MC. From cost-effectiveness ratios to resource allocation: where to draw the line? In: Sloan FA, ed. Valuing health care. New York: Cambridge University Press, 1995:Chapter 8.
67. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: W.B. Saunders, 1980.
68. Welch HG, Walsh JS, Larson EB. The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort. J Am Geriatr Soc 1992;40:221-4.
69. Wimo A, Mattson B, Krakau I, et al. Cost-utility analysis of group living in dementia care. Int J Technol Assess Health Care 1995;11: 49-65.
70. Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986;26: 260-6.
71. Zarit SH, Zarit JM. Families under stress: interventions for caregivers of senile dementia patients. Psychotherapy 1983;19:461-71.